In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 221 to 230 of 373

TitleTypeExpected publication date
Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]Technology appraisal guidanceTBC
NY-ESO-1 T-cells for treating synovial sarcoma ID1286Technology appraisal guidanceTBC
Obecabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia [ID6347]Technology appraisal guidance
Obeticholic acid for treating liver fibrosis in people with steatohepatitis [ID1645]Technology appraisal guidanceTBC
Obinutuzumab with immunosuppressive therapies for treating lupus nephritis [ID6420]Technology appraisal guidance
Obsessive-compulsive disorder and body dysmorphic disorder: assessment and managementNICE guidelineTBC
Odevixibat for treating cholestasis and pruritus in Alagille Syndrome [ID6181]Technology appraisal guidanceTBC
Olezarsen for treating familial chylomicronaemia syndrome [ID6585]Technology appraisal guidanceTBC
Omburtamab for treating relapsed neuroblastoma [ID1664]Technology appraisal guidanceTBC
Optical Coherence Tomography to guide percutaneous coronary interventionInterventional procedures guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All